Andrew Guggenhime - May 18, 2022 Form 4 Insider Report for Metacrine, Inc. (MTCR)

Role
Director
Signature
/s/ Michael York, Attorney-in-fact
Stock symbol
MTCR
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
4
Date filed
9/6/2022, 07:21 PM
Previous filing
Apr 20, 2022
Next filing
Jul 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2023 annual meeting of stockholders.